Eye Patch Therapy for Central Serous Retinopathy (CSR)

Completed · Phase 1

Conditions studied: Central Serous Retinopathy (CSR)

In brief

First, this study will investigate the viability of 24-hour eye patching as a potential treatment modality for CSR. Second, this study will assess a potential physiologic explanation for CSR, namely if inhibition of photic stimulation of the diseased retina will aid in ameliorating disease severity and disease duration.

Key facts

Study ID

NCT02036632

Run by

Washington University School of Medicine

People needed

12

Starts

2012-11-01

Expected to finish

2015-01-01

Last updated by the study team

2015-06-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults 18 years of age and older
• Both males and females
• Patients diagnosed with active central serous retinopathy
• Patients who are willing to use an eye patch in the affected eye for 24 hours
• Patients who are able to make the follow up appointments as required by the study

You may not qualify if…

• Individuals under 18 years of age
• Patients with vision less than 20/40 in the unaffected eye.
• Patients who are not able to undergo mfERG testing in a realiable manner.

Where it is running

• Washington Universtiy School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.